The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chronic Pain Treatment Market Research Report 2024
Synopsis
Chronic pain is pain that carries on for longer than 12 weeks despite medication or treatment. Most people get back to normal after pain following an injury or operation. But sometimes the pain carries on for longer or comes on without any history of an injury or operation.
The global Chronic Pain Treatment market was valued at US$ 79690 million in 2023 and is anticipated to reach US$ 126790 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over the age of 60 will nearly double, from 12% to 22%. In addition, the prevalence of chronic pain in nursing home seniors is very high and has become a serious problem in nursing facilities. Globally, rising prevalence of chronic diseases is one of the major healthcare burdens, affecting high-income as well as low- and middle-income countries. Due to the increasing prevalence of chronic diseases, various treatments such as medication, physical therapy, and psychotherapy are widely used through which pain can be managed.
This report aims to provide a comprehensive presentation of the global market for Chronic Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Pain Treatment.
Report Scope
The Chronic Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Segment by Type
Drugs
Devices
Segment by Application
Hospitals
Clinics
Nursing Homes
Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Chronic pain is pain that carries on for longer than 12 weeks despite medication or treatment. Most people get back to normal after pain following an injury or operation. But sometimes the pain carries on for longer or comes on without any history of an injury or operation.
The global Chronic Pain Treatment market was valued at US$ 79690 million in 2023 and is anticipated to reach US$ 126790 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over the age of 60 will nearly double, from 12% to 22%. In addition, the prevalence of chronic pain in nursing home seniors is very high and has become a serious problem in nursing facilities. Globally, rising prevalence of chronic diseases is one of the major healthcare burdens, affecting high-income as well as low- and middle-income countries. Due to the increasing prevalence of chronic diseases, various treatments such as medication, physical therapy, and psychotherapy are widely used through which pain can be managed.
This report aims to provide a comprehensive presentation of the global market for Chronic Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Pain Treatment.
Report Scope
The Chronic Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Segment by Type
Drugs
Devices
Segment by Application
Hospitals
Clinics
Nursing Homes
Research Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Pain Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drugs
1.2.3 Devices
1.3 Market by Application
1.3.1 Global Chronic Pain Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Nursing Homes
1.3.5 Research Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Pain Treatment Market Perspective (2019-2030)
2.2 Chronic Pain Treatment Growth Trends by Region
2.2.1 Global Chronic Pain Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chronic Pain Treatment Historic Market Size by Region (2019-2024)
2.2.3 Chronic Pain Treatment Forecasted Market Size by Region (2025-2030)
2.3 Chronic Pain Treatment Market Dynamics
2.3.1 Chronic Pain Treatment Industry Trends
2.3.2 Chronic Pain Treatment Market Drivers
2.3.3 Chronic Pain Treatment Market Challenges
2.3.4 Chronic Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Pain Treatment Players by Revenue
3.1.1 Global Top Chronic Pain Treatment Players by Revenue (2019-2024)
3.1.2 Global Chronic Pain Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Pain Treatment Revenue
3.4 Global Chronic Pain Treatment Market Concentration Ratio
3.4.1 Global Chronic Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Pain Treatment Revenue in 2023
3.5 Chronic Pain Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Pain Treatment Product Solution and Service
3.7 Date of Enter into Chronic Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Pain Treatment Breakdown Data by Type
4.1 Global Chronic Pain Treatment Historic Market Size by Type (2019-2024)
4.2 Global Chronic Pain Treatment Forecasted Market Size by Type (2025-2030)
5 Chronic Pain Treatment Breakdown Data by Application
5.1 Global Chronic Pain Treatment Historic Market Size by Application (2019-2024)
5.2 Global Chronic Pain Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chronic Pain Treatment Market Size (2019-2030)
6.2 North America Chronic Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chronic Pain Treatment Market Size by Country (2019-2024)
6.4 North America Chronic Pain Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Pain Treatment Market Size (2019-2030)
7.2 Europe Chronic Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chronic Pain Treatment Market Size by Country (2019-2024)
7.4 Europe Chronic Pain Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pain Treatment Market Size (2019-2030)
8.2 Asia-Pacific Chronic Pain Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chronic Pain Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Chronic Pain Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Pain Treatment Market Size (2019-2030)
9.2 Latin America Chronic Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chronic Pain Treatment Market Size by Country (2019-2024)
9.4 Latin America Chronic Pain Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pain Treatment Market Size (2019-2030)
10.2 Middle East & Africa Chronic Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chronic Pain Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Chronic Pain Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Chronic Pain Treatment Introduction
11.1.4 Eli Lilly and Company Revenue in Chronic Pain Treatment Business (2019-2024)
11.1.5 Eli Lilly and Company Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Chronic Pain Treatment Introduction
11.2.4 GlaxoSmithKline Revenue in Chronic Pain Treatment Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Chronic Pain Treatment Introduction
11.3.4 Pfizer Revenue in Chronic Pain Treatment Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Detail
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Chronic Pain Treatment Introduction
11.4.4 Medtronic Revenue in Chronic Pain Treatment Business (2019-2024)
11.4.5 Medtronic Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Chronic Pain Treatment Introduction
11.5.4 Abbott Laboratories Revenue in Chronic Pain Treatment Business (2019-2024)
11.5.5 Abbott Laboratories Recent Development
11.6 Boston Scientific Corporation
11.6.1 Boston Scientific Corporation Company Detail
11.6.2 Boston Scientific Corporation Business Overview
11.6.3 Boston Scientific Corporation Chronic Pain Treatment Introduction
11.6.4 Boston Scientific Corporation Revenue in Chronic Pain Treatment Business (2019-2024)
11.6.5 Boston Scientific Corporation Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Chronic Pain Treatment Introduction
11.7.4 Novartis AG Revenue in Chronic Pain Treatment Business (2019-2024)
11.7.5 Novartis AG Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Chronic Pain Treatment Introduction
11.8.4 Johnson & Johnson Revenue in Chronic Pain Treatment Business (2019-2024)
11.8.5 Johnson & Johnson Recent Development
11.9 AstraZeneca PLC
11.9.1 AstraZeneca PLC Company Detail
11.9.2 AstraZeneca PLC Business Overview
11.9.3 AstraZeneca PLC Chronic Pain Treatment Introduction
11.9.4 AstraZeneca PLC Revenue in Chronic Pain Treatment Business (2019-2024)
11.9.5 AstraZeneca PLC Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Detail
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Chronic Pain Treatment Introduction
11.10.4 Bristol-Myers Squibb Revenue in Chronic Pain Treatment Business (2019-2024)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Becton, Dickinson and Company
11.11.1 Becton, Dickinson and Company Company Detail
11.11.2 Becton, Dickinson and Company Business Overview
11.11.3 Becton, Dickinson and Company Chronic Pain Treatment Introduction
11.11.4 Becton, Dickinson and Company Revenue in Chronic Pain Treatment Business (2019-2024)
11.11.5 Becton, Dickinson and Company Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Chronic Pain Treatment Introduction
11.12.4 Sanofi Revenue in Chronic Pain Treatment Business (2019-2024)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
